Categories | Inventors

Aptamer-siRNA Chimera Targeting RORgammat in Th17 Cells for Topical Therapy of Psoriasis


OHSU # 1896

Technology Overview:

Researchers at Oregon Health & Science University and at the Portland VA Medical Center have discovered and validated a novel aptamer-siRNA chimera targeting RORgammat in Th17 cells for topical treatment of psoriasis. If interested in learning more, please contact the Office of Technology Transfer and Business Development ( and reference Tech Id No. 1896.



Notice of allowanceUnited States

Other Patents Filed


For more information, contact:

Travis Cook
Senior Technology Development Manager